A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children
Clinical trial NCT00000849 · COMPLETED
Trial details
- NCT number
- NCT00000849
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.